Results for tag: "Toll Like Receptor"

The Toll Like Receptor (TLR) market is a key component of drug discovery. TLRs are a family of proteins that recognize and respond to foreign molecules, such as bacteria and viruses. They play an important role in the body's immune system, helping to identify and respond to potential threats. TLRs are also involved in the development of autoimmune diseases, cancer, and other diseases. As such, they are a major target for drug discovery. TLR-based drug discovery is a rapidly growing field, with many companies investing in research and development. Companies are developing TLR-based therapies for a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. These therapies are designed to target specific TLRs, allowing for more targeted and effective treatments. Companies in the TLR market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more